No Surgery for Stuttering Priapism

Journal of Urology

Volumn 181, Issue 2, 2009, Pages 450-451

  Burnett, Arthur L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; NITRIC OXIDE; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; PSEUDOEPHEDRINE; TERBUTALINE;

BLOOD DYSCRASIA; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; CLINICAL TRIAL; DECOMPRESSION SURGERY; DRUG EFFICACY; EDITORIAL; ERECTILE DYSFUNCTION; HEMOGLOBINOPATHY; HUMAN; ISCHEMIC PRIAPISM; PRIAPISM; PRIORITY JOURNAL; STUTTERING PRIAPISM;

CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; DECISION MAKING; HUMANS; ISCHEMIA; MALE; PATIENT SELECTION; PENIS; PRIAPISM; PROGNOSIS; RISK ASSESSMENT; SAFETY MANAGEMENT; SEVERITY OF ILLNESS INDEX; UROLOGIC SURGICAL PROCEDURES;

EID: 58149202061     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.11.075     Document Type: Editorial

References (5)

1. Glina S., Burnett A.L., Becher E., Brock G., and Hellstrom W. Priapism: reasons for failure by Frank Hinman Jr. J Sex Med 4 (2007) 1539
2. Montague D.K., Jarow J., Broderick G.A., Dmochowski R.R., Heaton J.P., Lue T.F., et al. American Urological Association guideline on the management of priapism. J Urol 170 (2003) 1318
3. Champion H.C., Bivalacqua T.J., Takimoto E., Kass D.A., and Burnett A.L. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci U S A 102 (2005) 1661
4. Burnett A.L., Bivalacqua T.J., Champion H.C., and Musicki B. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. J Sex Med 3 (2006) 1077
5. Finley D. Glucose-6-phosphate dehydrogenase deficiency associated stuttering priapism: report of a case. J Sex Med (2008) Epub ahead of print.